维普期刊资源整合服务平台（V6.5）

179篇 您的检索式：作者名="HAIOUN C"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Prognostic significance of survivin expression in diffuse large B-cell lymphomas显示文摘	Adida C Haioun C Gaulard P	2000	Blood2000，96，5：	1
2	Prognostic significance of survivinexpression in diffuse large B- cell lymphomas 显示文摘	Haioun C Gaulard P	2000	Blood2000，96，5：	1
3	Low grade B cell mucosa associated lymphoid tissue lymphoma of the stomach:clinical and endoscopic features, treatment and outcome显示文摘	Blazquez M Haioun C Chaumette	1992	Gut1992，33，：	1
4	Prognostic significance of survivin expression in diffuse large B-cell lymphomas显示文摘	Haioun C Gaulard P	2000	Blood2000，96，5：	1
5	Survival benefit of high - dose therapy in poor - risk aggressive non- Hodgkin' s lymphoma: final analysis of the prospective LNH87 - 2 protocol - a groupe d ' Etude des lymphomes de l' Aduhe study显示文摘	Haioun C Lepage E Gisselbrecht C	2000	J Clin Oncol2000，18，：	1
6	fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome显示文摘	Haioun C Itti E Rahmouni A	2005	Blood2005，106，：	1
7	Prognostic significance of survivin expression in diffuse large B - cell lymphomas 显示文摘	Adida C Haioun C Gaulard P	2000	Blood2000，96，5：	1
8	Report on the first International Workshop on Interim-PET-Scan in Lymphoma显示文摘	Meignan M Gallamini A Haioun C	2009	Leuk Lymphoma2009，50，8：	1
9	CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma:a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte显示文摘	Delarue R Haioun C Ribrag V	2013	Blood2013，121，1：	1
10	Prognostic significance of surviving expression in diffuse large B-cell lymphomas显示文摘	Adida C Haioun C Gaulard P	2000	Blood2000，96，：	1
11	Prognostic significance of survivin expression in diffuse large B-cell lymphomas显示文摘	Adida C Haioun C Gaulard P	2000	Blood2000，96，：	1
12	CHOPand DHAP plus rituximab followed by autologousstem cell transplantation in mantlecell lymphoma: a phase 2 study from theGroupe dtude des Lymphomes de l'Adulte显示文摘	Delarue R Haioun C Ribrag V	2013	Blood2013，，：	1
13	Rituximab ( anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase Ⅱ study 显示文摘	Coiffier B Haioun C Ketterer N	1998	Blood1998，92，：	1
14	Early 18F-FDG PET for prediction ofprognosis in patients with diffuse large B-cell lymphoma : SUV-basedassessment vereus visual analysis 显示文摘	Lin C Itti E Haioun C	2007	J Nucl Med2007，48，10：	1
15	Rituximab ( anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase Ⅱ study 显示文摘	Coiffier B Haioun C Ketterer N	1998	Blood1998，92，6：	1
16	Fluoro-2-deoxy-D-glu cose positron emission tomography ( FDG PET) in aggressive lymphoma: an early prognostic tool for predicting patient out- come显示文摘	Haioun C Itti E Rahmouni A	2005	Blood2005，16，：	1
17	Prognostic significance of survivin expression in diffuse large B-cell lymphomas显示文摘	Adida C Haioun C Gaulard P	2000	Blood2000，96，5：	1
18	Rituximab(anti-CD20monoclonal anti-body)for the treatment of patients with relapsing or refractory aggressive lymphoma:a multicenter phase II study显示文摘	Coiffier B Haioun C Ketterer N	1998	Blood1998，92，6：	1
19	18F-FDG positron imaging in clinical management of lymphoma patients 显示文摘	Talbot JN Haioun C Rain JD	2001	Crit Rev Oncol Hematol2001，38，3：	1
20	Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lym- phoma:importance of the reference background显示文摘	Itti E Juweid ME Haioun C	2010	J Nucl Med2010，51，12：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示